<p>Fentanyl is a potent, fast-acting synthetic opioid that has played a major role in the opioid overdose crisis in the United States for over five decades, with opioid-related deaths increasing sharply in recent years. This study investigates the behavioral, histological, and molecular changes in the hippocampus of rats subjected to sub-acute fentanyl exposure. Two groups of rats were studied: one group received multiple fentanyl injections over approximately one week, while the control group received no fentanyl. A battery of behavioral tests related to memory and depression—including the Y-maze, shuttle box, tail suspension test, elevated plus maze, Barnes maze, Morris water maze, and forced swimming test—was administered. Electrophysiological assessments, including field potential recording and electromyography (EMG), were conducted to evaluate neural activity. Western blot analysis was performed to quantify the expression of brain-derived neurotrophic factor (BDNF) and RE1-silencing transcription factor (REST), while immunohistochemical analyses assessed hippocampal cellular alterations. Results showed that sub-acute fentanyl administration impaired behavioral performance in memory assessment tests (Y maze (<i>P</i> &lt; 0.05), shuttle box (<i>P</i> &lt; 0.01)). However, fentanyl did not alter spatial memory assessed by Morris water maze and Barnes maze relative to controls. Moreover, LTP was decreased in fentanyl group compared to the control group (<i>P</i> &lt; 0.01). Locomotor activity (<i>P</i> &lt; 0.05) and EMG latency (<i>P</i> &lt; 0.01) were also diminished following fentanyl exposure. Notably, increased astrogliosis (<i>P</i> &lt; 0.01) and astrocyte reactivity (<i>P</i> &lt; 0.001) were observed, indicating significant disruptions in astrocyte neurobiology. Furthermore, BDNF expression was reduced (<i>P</i> &lt; 0.001), whereas REST expression was elevated (<i>P</i> &lt; 0.001) in the fentanyl-treated group. These findings offer initial insights into the neurobiological effects of fentanyl, underscoring the potential role of astrocytes in fentanyl-induced cognitive dysfunction and the broader implications for memory-related neuroregeneration.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Astrocytic disruption and cognitive impairment following sub-acute fentanyl administration in male rats

  • Sina Dolatshahi,
  • Hossein Salehi Omran,
  • Amirreza Beirami,
  • Maral Hasanzadeh,
  • Amirmahdi Zeynalzadeh,
  • Siavash Parvardeh,
  • Sara Ashtari,
  • Pardis Rabieyan Abianeh,
  • Proushat Shirvani,
  • Paniz Shirvani,
  • Seyed Mohammadmisagh Moteshakereh,
  • Fatemeh Navaei,
  • Amir-Hossein Bayat,
  • Mojtaba Sani,
  • Abbas Aliaghaei,
  • Meysam Hassani Moghaddam

摘要

Fentanyl is a potent, fast-acting synthetic opioid that has played a major role in the opioid overdose crisis in the United States for over five decades, with opioid-related deaths increasing sharply in recent years. This study investigates the behavioral, histological, and molecular changes in the hippocampus of rats subjected to sub-acute fentanyl exposure. Two groups of rats were studied: one group received multiple fentanyl injections over approximately one week, while the control group received no fentanyl. A battery of behavioral tests related to memory and depression—including the Y-maze, shuttle box, tail suspension test, elevated plus maze, Barnes maze, Morris water maze, and forced swimming test—was administered. Electrophysiological assessments, including field potential recording and electromyography (EMG), were conducted to evaluate neural activity. Western blot analysis was performed to quantify the expression of brain-derived neurotrophic factor (BDNF) and RE1-silencing transcription factor (REST), while immunohistochemical analyses assessed hippocampal cellular alterations. Results showed that sub-acute fentanyl administration impaired behavioral performance in memory assessment tests (Y maze (P < 0.05), shuttle box (P < 0.01)). However, fentanyl did not alter spatial memory assessed by Morris water maze and Barnes maze relative to controls. Moreover, LTP was decreased in fentanyl group compared to the control group (P < 0.01). Locomotor activity (P < 0.05) and EMG latency (P < 0.01) were also diminished following fentanyl exposure. Notably, increased astrogliosis (P < 0.01) and astrocyte reactivity (P < 0.001) were observed, indicating significant disruptions in astrocyte neurobiology. Furthermore, BDNF expression was reduced (P < 0.001), whereas REST expression was elevated (P < 0.001) in the fentanyl-treated group. These findings offer initial insights into the neurobiological effects of fentanyl, underscoring the potential role of astrocytes in fentanyl-induced cognitive dysfunction and the broader implications for memory-related neuroregeneration.